Patents by Inventor Jens Christian Højland Larsen

Jens Christian Højland Larsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biaryl phosphodiesterase inhibitors
    Patent number: 9051290
    Abstract: Novel biaryl compounds with phosphodiesterase inhibitory activity of general formula (I) below, wherein R1, R2, R3, X, Y, Z1, Z2, Z3, and Z4 have the meanings defined herein, as well as their use as therapeutic agents in the treatment of inflammatory diseases and conditions are described herein.
    Type: Grant
    Filed: April 28, 2011
    Date of Patent: June 9, 2015
    Assignee: LEO PHARMA A/S
    Inventors: Simon Feldbæk Nielsen, Anne Marie Horneman, Jesper Lau, Jens Christian Højland Larsen
  • [1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors
    Patent number: 8940761
    Abstract: The present invention relates to novel [1,2,4]triazolopyridine compounds with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
    Type: Grant
    Filed: December 19, 2012
    Date of Patent: January 27, 2015
    Assignee: Leo Pharma A/S
    Inventors: Simon Feldbæk Nielsen, Jens Christian Højland Larsen
  • [1,2,4]TRIAZOLOPYRIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
    Publication number: 20140329853
    Abstract: The present invention relates to novel [1,2,4]triazolopyridine compounds with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
    Type: Application
    Filed: December 19, 2012
    Publication date: November 6, 2014
    Inventors: Simon Feldbæk Nielsen, Jens Christian Højland Larsen
  • VEGF-2 receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof
    Patent number: 8350026
    Abstract: The invention relates to compounds of general formula (I) wherein W, D, E, G, J, L, R1, R2, R3, R4, R5 and Y are as defined herein, and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use—alone or in combination with one or more other pharmaceutically active compounds—in therapy, for treating diseases associated with deregulated angiogenesis, such as cancer and skin and eye diseases.
    Type: Grant
    Filed: August 27, 2009
    Date of Patent: January 8, 2013
    Assignee: Leo Pharma A/S
    Inventors: Jakob Felding, Xifu Liang, Anne Marie Horneman, Tina Dahlerup Poulsen, Jens Christian Højland Larsen
  • Phosphodiesterase inhibitors
    Patent number: 8338431
    Abstract: The present invention relates to a compound according to formula I, wherein X, A, G, E, R1, R2, R3 are as shown herein; and pharmaceutically acceptable salts, hydrates, N-oxides or solvates hereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.
    Type: Grant
    Filed: February 26, 2008
    Date of Patent: December 25, 2012
    Assignee: Leo Pharma A/S
    Inventors: Ravindra Babu Bollu, Jakob Felding, Simon Feldbæk Nielsen, Jens Christian Højland Larsen
  • NOVEL VEGF-2 RECEPTOR AND PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF
    Publication number: 20110190282
    Abstract: The invention relates to compounds of general formula (I) wherein W, D, E, G, J, L, R1, R2, R3, R4, R5 and Y are as defined herein, and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use—alone or in combination with one or more other pharmaceutically active compounds—in therapy, for treating diseases associated with deregulated angiogenesis, such as cancer and skin and eye diseases.
    Type: Application
    Filed: August 27, 2009
    Publication date: August 4, 2011
    Applicant: LEO PHARMA A/S
    Inventors: Jakob Felding, Xifu Liang, Anne Marie Horneman, Tina Dahlerup Poulsen, Jens Christian Højland Larsen
  • NOVEL PHOSPHODIESTERASE INHIBITORS
    Publication number: 20100099688
    Abstract: The present invention relates to a compound according to formula I, wherein X, A, G, E, R1, R2, R3 are as shown herein; and pharmaceutically acceptable salts, hydrates, N-oxides or solvates hereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.
    Type: Application
    Filed: February 26, 2008
    Publication date: April 22, 2010
    Applicant: Leo Pharma A/S
    Inventors: Jakob Felding, Simon Feldbaek Nielsen, Jens Christian Højland Larsen, Bollu Ravindra Babu